Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 166 (RN7SKP166) is a predicted pseudogene related to the RN7SK gene, which encodes 7SK small nuclear RNA—a noncoding RNA that regulates transcription elongation by RNA polymerase II via sequestration of the positive transcription elongation factor b (P-TEFb)[1][2][3]. There is no evidence that RN7SKP166 is expressed, functional, or involved in any biological processes, diseases, or therapeutic responses. The functional insights and roles described for 7SK snRNA and its parent gene do not apply to this pseudogene. *If you are seeking information about 7SK snRNA or its protein complex, reference RN7SK or 7SK snRNA—not RN7SKP166, which is not a target or biologically relevant entity in current biomedical literature.*
None known for RN7SKP166.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 166 (RN7SKP166).